Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
2019 · Nature Communications · 175 citations
https://doi.org/10.1038/s41467-019-10652-9
M
Miriam M. Yeung
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.2K
Citations
9
h-index
9
i10-index
Miriam M. Yeung is an academic researcher from Hong Kong Polytechnic University. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 9, co-authored 37 publications.
ORCID: 0000-0002-9455-1887Papers by this author
worksHBO1 is required for the maintenance of leukaemia stem cells
2019 · Nature · 170 citations
https://doi.org/10.1038/s41586-019-1835-6
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
2020 · PLoS Medicine · 34 citations
https://doi.org/10.1371/journal.pmed.1003363
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
2023 · Clinical and Translational Radiation Oncology · 5 citations
https://doi.org/10.1016/j.ctro.2023.100682
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat